Powerful new weight-loss drug helps patients cut knee pain in half
A powerful experimental weight-loss drug helped people with knee osteoarthritis lose about 25% of their body weight at the highest dose, while roughly two-thirds experienced at least a 50% reduction in knee pain. The findings suggest retatrutide could transform treatment for millions suffering from painful arthritis, although its ability to prevent further joint damage remains unknown.
Key Takeaways
- A powerful experimental weight-loss drug helped people with knee osteoarthritis lose about 25% of their body weight at the highest dose, while roughly two-thirds experienced at least a 50% reduction in knee pain.
- The findings suggest retatrutide could transform treatment for millions suffering from painful arthritis, although its ability to prevent further joint damage remains unknown.
- Full details and original dispatch available below.
A powerful experimental weight-loss drug helped people with knee osteoarthritis lose about 25% of their body weight at the highest dose, while roughly two-thirds experienced at least a 50% reduction in knee pain. The findings suggest retatrutide could transform treatment for millions suffering from painful arthritis, although its ability to prevent further joint damage remains unknown.
Original Publisher Attribution
This summary was curated from ScienceDaily.